SANOFI S.A. revenue for the last year amounted to 40.02 B CHF, the most of which — 35.21 B CHF — came from its highest performing source at the moment, Biopharma, the year earlier bringing 30.37 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought SANOFI S.A. 17.20 B CHF, and the year before that — 18.09 B CHF.